Related Experiment Videos
Possible relationship between pulmonary hypertension and prostaglandins
Prostaglandins and Medicine
|July 1, 1981
Summary
Prostaglandins (PG) regulate pulmonary circulation in children with congenital heart defects. Elevated prostaglandin-like activities (PGLA) suggest a role in developing pulmonary hypertension in these patients.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Biochemistry
Background:
- Congenital heart defects with left-to-right shunts can impact pulmonary circulation.
- Pulmonary hypertension is a serious complication in some pediatric cardiac patients.
- Prostaglandins (PG) are implicated in regulating vascular tone and pulmonary circulation.
Purpose of the Study:
- To investigate the role of Prostaglandin-Like Materials (PLMs) in children with congenital heart defects.
- To determine if altered Prostaglandin-Like Activities (PGLA) are associated with pulmonary hypertension in this population.
- To explore the relationship between PGs and pulmonary circulation regulation.
Main Methods:
- Study included 20 children with congenital heart defects and left-to-right shunts, divided into normal pulmonary arterial pressure and pulmonary hypertension groups.
- Blood samples (pulmonary venous and arterial) were collected during cardiac catheterization.
- Prostaglandin-Like Materials (PLMs) were extracted and assayed for Prostaglandin-Like Activities (PGLA) using a rat stomach fundus bioassay.
Main Results:
- In children with normal pulmonary arterial pressure, the ratio of pulmonary venous to pulmonary arterial PGLA (PV/PA-PGLA) was consistently less than one.
- In children with pulmonary hypertension, 80% exhibited a PV/PA-PGLA ratio of one or greater.
- A PV/PA-PGLA ratio less than one was observed in only 20% of patients with pulmonary hypertension.
Conclusions:
- Data support the established role of prostaglandins (PG) in maintaining normal pulmonary circulation.
- Elevated PGLA levels in pulmonary arterial blood suggest a significant role for PGs in the development of pulmonary hypertension in pediatric cardiac patients.
- These findings highlight the potential involvement of prostaglandins in the pathophysiology of pulmonary hypertension secondary to congenital heart disease.